journal article·2022-01

A novel substrate based on electrospun polyurethane nanofibers and electrosprayed polyvinyl alcohol microparticles for recombinant human erythropoietin delivery

Elmira Ghanbari, Atefeh Solouk, Rouhollah Mehdinavaz Aghdam, Masoumeh Haghbin Nazarpak, Seyed Hossein Ahmadi Tafti

Publisher page

Abstract

Abstract After myocardial infarction caused by a heart attack, endothelial cells need to be preserved in order to regenerate new capillaries. Moreover, sufficient mechanical support is necessary for the infarcted myocardium to pump the blood. Herein, we designed a novel substrate containing polyurethane (PU) nanofibrous layers and recombinant human erythropoietin (rhEPO)‐loaded microparticles for both controlled releases of rhEPO and mechanical support of myocardium. In this system, the single‐layer (SL) and double‐layer (DL) PU nanofibers were electrospun, and then microparticles with different rhEPO:polyvinyl alcohol (PVA) ratios were electrosprayed on the layers. The in vitro release behavior of rhEPO from SL substrates was not satisfactory, and then the study focused on DL patches in which the release profile was in accordance with Korsmeyer–Peppas model. The release exponent of 0.89 for the DL PU/120PVA:1rhEPO represented zero‐order release. The results inferred that these substrates possessed highly tailored mechanical properties; Young's modulus and ultimate tensile strength of the substrates were 74–172 kPa and 7.4–9.9 MPa, respectively. The rhEPO release from the substrates was leading to the proper adhesion of endothelial cells and more than 95% cell viability. The results indicated that the patch of elastic nanofibers and microparticles offered a potential substrate for simultaneous rhEPO delivery to endothelial cells and also mechanically supporting the infarcted myocardium.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Electrohydrodynamics and Fluid Dynamics · Tissue Engineering and Regenerative Medicine

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biomedical Engineering Amirkabir University of Technology (Tehran Polytechnic) Tehran Iran

School of Metallurgy and Materials Engineering College of Engineering, University of Tehran Tehran Iran

New Technologies Research Center Amirkabir University of Technology (Tehran Polytechnic) Tehran Iran

Department of Medicine Tehran University of Medical Science Tehran Iran

References (62)

Show source-provided references
1. A.S.Jaffe H.A.K.Germany J.R.Denmark B.Chaitman P.M.C.Denmark M.Dellborg I.G.J.Bassand C.France W.Wijns C.Investigation G.Paul C.Canada Joseph S.Alpert HarveyD.&B. Group E.C.G. Group&Universal definition of myocardial infarction Kristian ThygesenWhite on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction (2007) 2525–2538.https://doi.org/10.1093/eurheartj/ehm355.10.1093/eurheartj/ehm355 ↗
2. Margulies E · 2012
3. 10.1016/S0008-6363(02)00256-010.1016/S0008-6363(02)00256-0 ↗
4. 10.1016/0735-1097(89)90360-410.1016/0735-1097(89)90360-4 ↗
5. 10.1161/01.CIR.81.4.116110.1161/01.CIR.81.4.1161 ↗
6. 10.1016/j.jacc.2006.06.00510.1016/j.jacc.2006.06.005 ↗
7. J.M.Dang K.W.Leong Natural polymers for gene delivery and tissue engineering B 58(2006)487–499.https://doi.org/10.1016/j.addr.2006.03.001.10.1016/j.addr.2006.03.001 ↗
8. R.J.Lee M.L.Springer W.E.Blanco‐bose R.Shaw P.C.Ursell H.M.Blau Basic Science Reports (2000)4–8.
9. M.G.St J.Sutton N.Sharpe Clinical Cardiology: New Frontiers Left Ventricular Remodeling After Myocardial Infarction Pathophysiology and Therapy (2000)2981–2988.10.1161/01.CIR.101.25.2981 ↗
10. 10.1006/mvre.2002.242610.1006/mvre.2002.2426 ↗
11. 10.1093/ndt/gfg54710.1093/ndt/gfg547 ↗
12. 10.1093/cvr/cvn15410.1093/cvr/cvn154 ↗
13. 10.1016/S0168-3659(98)00070-410.1016/S0168-3659(98)00070-4 ↗
14. 10.1016/S0006-291X(03)01503-110.1016/S0006-291X(03)01503-1 ↗
15. 10.1182/blood.V77.3.419.41910.1182/blood.V77.3.419.419 ↗
16. 10.1097/01.fjc.0000140209.04675.c310.1097/01.fjc.0000140209.04675.c3 ↗
17. 10.1016/j.jacc.2005.03.04410.1016/j.jacc.2005.03.044 ↗
18. 10.1016/j.mser.2007.08.00110.1016/j.mser.2007.08.001 ↗
19. 10.1177/08853282990140010410.1177/088532829901400104 ↗
20. 10.1088/1748-6041/6/5/05500110.1088/1748-6041/6/5/055001 ↗
21. 10.1016/j.actbio.2011.04.02810.1016/j.actbio.2011.04.028 ↗
22. 10.1089/ten.tea.2010.044110.1089/ten.tea.2010.0441 ↗
23. 10.1016/j.msec.2016.02.05110.1016/j.msec.2016.02.051 ↗
24. 10.1016/j.actbio.2016.11.01410.1016/j.actbio.2016.11.014 ↗
25. 10.1016/S0142-9612(02)00227-210.1016/S0142-9612(02)00227-2 ↗
26. 10.1016/j.biomaterials.2010.02.00510.1016/j.biomaterials.2010.02.005 ↗
27. O.Access We are IntechOpen the world' s leading publisher of open access books built by scientists for scientists TOP 1% (n.d.).
28. 10.1080/00914037.2013.76916510.1080/00914037.2013.769165 ↗
29. 10.1002/jbm.b.3178610.1002/jbm.b.31786 ↗
30. 10.1016/j.mvr.2007.05.00610.1016/j.mvr.2007.05.006 ↗
31. 10.1016/S0021-8502(99)00034-810.1016/S0021-8502(99)00034-8 ↗
32. 10.1016/j.jaerosci.2008.07.00310.1016/j.jaerosci.2008.07.003 ↗
33. 10.1063/1.179006210.1063/1.1790062 ↗
34. N.Lavielle A.He G.Schlatter L.Tho R.M.Rossi A.Popa Straightforward Approach for Fabricating Hierarchically Structured (2013).
35. 10.1002/jbm.b.3004110.1002/jbm.b.30041 ↗
36. 10.1016/j.jconrel.2011.05.01810.1016/j.jconrel.2011.05.018 ↗
37. 10.1007/s10853-009-4035-110.1007/s10853-009-4035-1 ↗
38. Advances in drug delivery via electrospun and electrosprayed nanomaterials
39. 10.1002/jbm.a.3149910.1002/jbm.a.31499 ↗
40. 10.1016/0304-3886(95)00041-810.1016/0304-3886(95)00041-8 ↗
41. 10.1016/j.ijpharm.2006.06.03510.1016/j.ijpharm.2006.06.035 ↗
42. 10.1016/j.jcis.2006.06.03710.1016/j.jcis.2006.06.037 ↗
43. 10.1016/j.msec.2016.03.07610.1016/j.msec.2016.03.076 ↗
44. 10.1016/j.jconrel.2007.03.02210.1016/j.jconrel.2007.03.022 ↗
45. 10.1179/174327807x23890910.1179/174327807x238909 ↗
46. 10.1016/j.biomaterials.2007.08.03510.1016/j.biomaterials.2007.08.035 ↗
47. 10.1016/j.matlet.2011.06.01810.1016/j.matlet.2011.06.018 ↗
48. 10.1016/j.msec.2016.05.08310.1016/j.msec.2016.05.083 ↗
49. 10.1016/S0168-3659(00)00339-410.1016/S0168-3659(00)00339-4 ↗
50. 10.1002/pi.497210.1002/pi.4972 ↗
51. H.Sciences Review Kinetic Modeling on Drug Release from Controlled Drug Delivery Systems 67(2010)217–223.
52. 10.1073/pnas.193040610010.1073/pnas.1930406100 ↗
53. 10.1016/j.jconrel.2008.01.01110.1016/j.jconrel.2008.01.011 ↗
54. 10.1016/s0003‐4975(01)02513‐910.1016/s0003‐4975(01)02513‐9 ↗
55. 10.1016/j.biomaterials.2003.08.04210.1016/j.biomaterials.2003.08.042 ↗
56. 10.1016/j.jconrel.2014.04.01810.1016/j.jconrel.2014.04.018 ↗
57. 10.1002/(SICI)1097-4628(19961024)62:4<631::AID-APP6>3.0.CO;2-U10.1002/(SICI)1097-4628(19961024)62:4<631::AID-APP6>3.0.CO;2-U ↗
58. 10.1002/term10.1002/term ↗
59. 10.1080/00914037.2017.132066110.1080/00914037.2017.1320661 ↗
60. 10.1016/j.jcis.2009.10.00210.1016/j.jcis.2009.10.002 ↗
61. 10.1177/088532820809908610.1177/0885328208099086 ↗
62. 10.1088/1748-6041/4/4/04410610.1088/1748-6041/4/4/044106 ↗